The attention-deficit/hyperactivity disorder medication-related attitudes of patients and their parents

Journal of Child and Adolescent Psychopharmacology

Volumn 18, Issue 5, 2008, Pages 461-473

  Harpur, Ruth Ann ^a   Thompson, Margaret ^a   Daley, David ^b   Abikoff, Howard ^c   Sonuga Barke, Edmund J S ^a,c,d,e  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b BANGOR UNIVERSITY   (United Kingdom)

^c NEW YORK UNIVERSITY   (United States)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; ATOMOXETINE; DEXAMPHETAMINE; DEXMETHYLPHENIDATE; METHYLPHENIDATE;

ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; FEMALE; HUMAN; MALE; OUTCOME ASSESSMENT; PARENTAL ATTITUDE; PATIENT ATTITUDE; PRESCHOOL CHILD; RATING SCALE; SCHOOL CHILD; SOUTHAMPTON ADHD MEDICATION BEHAVIOUR AND ATTITUDES SCALE; STIGMA; STRUCTURED QUESTIONNAIRE; SUSTAINED DRUG RELEASE; TREATMENT OUTCOME;

EID: 54249114460     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2008.023     Document Type: Article

References (32)

1. American Psychiatric Association. Diagnostic and Statistical Manual for Mental Disorders. 4th ed. Washington D.C: American Psychiatric Association, 1994.
2. Ayalon L, Arean PA, Alvidrez J. Adherence to antidepressant medications in black and Latino elderly patients. Am J Geriatr Psychol 13:572-580, 2005.
3. Bachanas PJ, Roberts MC. Factors affecting children's attitudes toward healthcare and responses to stressful medical procedures. J Ped Psychol 30:261-275, 1995.
4. Banaschewski T, Coghill D, Santosh P, et al: Long-acting medications for the hyperkinetic disorders - A systematic review and European treatment guideline. Eur Child Adolesc Psychiatry 15:476-495, 2006.
5. Bowen J, Fenton T., Rappaport L. Stimulant medication and attention deficit-hyperactivity disorder. The child's perspective. Am J Disabled Child 145:291-295, 1991.
6. Buck D, Jacoby A, Baker GA, Chadwick DW. Factors influencing compliance with antiepileptic drug regimes. Seizure 6:87-93, 1997.
7. Bukstein OG. Satisfaction with treatment for attention-deficit/ hyperactivity disorder. Am J Managed Care 10:107-116, 2004.
8. Charach A, Ickowicz A, Schachar R. Stimulant treatment over five years: Adherence, effectiveness, and adverse effects. J Am Acad Child Adolesc Psychiatry 43:559-567, 2004.
9. Cohen NJ, Thompson L. Perceptions and attitudes of hyperactive children and their mothers regarding treatment with methylphenidate. Can J Psychiatry 27:40-42, 1982.
10. Conrad P. The meaning of medications: Another look at compliance. Soc Sci Med 20:29-37, 1985.
11. DePaola ML, Roberts MC, Blaiss MS, Frick PK, McNeal RE. Mothers' and children's perception of asthma medication. Children's Health Care 26:265-283, 1997.
12. Dopfner M, Steinhausen HC, Coghill D, et al: Factors related to health-related quality of life (HRQoL) among children with ADHD in Europe at entry into treatment. Eur Child Adoles Psychiatry 15(Suppl 1): 46-55, 2006.
13. dosReis S, Zito JM, Safer DJ, Soeken KL, Mitchell JW, Ellwood. Parental perceptions and satisfaction with stimulant medication for attention-deficit hyperactivity disorder. Dev Behav Ped 24:155-162, 2003.
14. Efron D, Jarman FC, Barker M. Child and parent perceptions of stimulant medication treatment in attention deficit hyperactivity disorder. J Pediatr Child Health 34:288-292, 1998.
15. Eiser C, Morse R. The measurement of quality of life in children: Past and future perspectives. JDBP 22:248-256, 2001.
16. Firestone P. Factors associated with children's adherence to stimulant medication. Am J Orthopsychiatry 52:447-457, 1982.
17. Freudenreich O, Cather C, Evins AE, Henderson DC, Hoff DC. Attitudes of schizophrenia outpatients toward psychiatric medications: Relationship to clinical variables and insight. J Clin Psychol 65:1372-1376, 2004.
18. Hackworth SR, McMahon RJ. Factors mediating children's attitudes. J Health Psychol 16:69-85, 1991.
19. Harpur, RA: ADHD medication related attitudes and behaviours. Unpublished doctoral dissertation. University of Southampton, UK, 2006.
20. Hazell P. Pharmacological management of attention-deficit hyperactivity disorder in adolescents - Special considerations. CNS Drugs 21:37-46, 2007.
21. Hoza B, Johnston C, Pillow DR, Ascough JC. Predicting treatment response for childhood attention-deficit/hyperactivity disorder: Introduction of a heuristic model to guide research. Appl Prev Psychol 11:215-229, 2006.
22. McNeal RE, Roberts MC, Barone VJ. Mothers' and children's perceptions of medication for children with attention-deficit hyperactivity disorder. Child Psychiatry Hum Dev 30:173-187, 2000.
23. Riley AW, Spiel G, Coghil D et al: Naturalistic-observational studies in the framework of ADHD health care. Child Adolesc Psychiatry 15(Suppl 1):38-45, 2006.
24. Sirey JA, Bruce ML, Alexopoulos GS, Perlick DA, Friedman SJ, Meyers BS. Perceived stigma and patient-rated severity of illness as predictors of antidepressant drug adherence. Psychiatr Serv 52:1615-1620, 2001.
25. Sleator EK. Measurement of compliance. Psychopharmacol Bull 21:1089-1093, 2001.
26. Stein MT, Wells R, Stephenson S. An adolescent who abruptly stops his medication for Attention-Deficit/Hyperactivity Disorder. Pediatrics 107:974-978, 2001.
27. Taylor E, Dopfner M, Sergeant J et al: European clinical guidelines for hyperkinetic disorder - first upgrade. Eur Child Adolesc Psychiatry 13(Suppl 1):I7-I30, 2004.
28. Taylor EA, Sonuga-Barke EJS. Attention Deficit Hyperactivity Disorder: A developmental lifespan perspective. In: Rutter, Taylor, Stevenson, Pine, Scott et al., eds. Rutter's Child & Adolescent Psychiatry. 5th ed. In press.
29. Thiruchelvam D, Charach A, Schachar RJ. Moderators and mediators of long-term adherence to stimulant treatment in children with ADHD. J Am Acad Child Adolesc Psychiatry 40:922-928, 2001.
30. Weiss M, Jain U, Garland J. Clinical suggestions for management of stimulant treatment in adolescents. Can J Psychiatry 45:717-723, 2000.
31. Willens TE. Mechanism of action of agents used in attention-deficit/ hyperactivity disorder. J Clin Psychiatry 67(Suppl 1):32-38, 2006.
32. Wrubel J, Moskowitz JT, Richards TA, Prakke H, Acree M, Folkman S. Pediatric adherence: Perspectives of mothers of children with HIV. Soc Sci Med 61:2423-2433, 2005.